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Abstract 
 
Type II Diabetes Mellitus has detrimental effects on the human body. A1C levels reflect the 
attachment of glucose to hemoglobin-the protein in red blood cells that carries oxygen. Elevated 
A1C levels are an indicator of how controlled diabetes is. Uncontrolled diabetes not only affects 
glucose levels, but has detrimental repercussions in other organs of the body, causing peripheral 
vascular disease, risk of developing dementia, periodontal or gum disease, skin infections, 
neuropathy in lower and upper extremities, renal damage, erectile dysfunction, decreased blood 
flow, and cardiac conditions among others. 
A diet low in calories positively affects glucose levels in the body. Type II Diabetes can be easily 
controlled when lifestyle modifications are included in the plan of care. Among those 
modifications, diet is an effective intervention for the management of this condition. 
Establishing a diet among the patients that have an elevated A1C is the plan of care and ultimate 
goal for this project. The Mediterranean diet has demonstrated decreased blood glucose levels, 
improved weight control and enhanced quality of life.  
Keywords: A1C, Type II diabetes, diet low in calories, glucose, Mediterranean diet. 
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Implementation of a Mediterranean Diet in Type II Diabetic Patients 
Problem Statement 
 Type II Diabetes, one of the most debilitating and chronic diseases, has become for a 
large amount of the population, an unmanageable disease affecting both adults and children. 
Current projections indicate that the number of individuals with diabetes will more than double 
from 2005 to 2050 (Miller et al., 2012). Compelling evidence from epidemiologic studies 
indicates that the current worldwide diabetes epidemic is due in large part to changes in diet and 
lifestyle. Excess adiposity is the most important risk factor for diabetes (Schulze & Hu, 2005). 
Maintaining a healthy body weight and avoiding weight gain during adulthood is the cornerstone 
of diabetes prevention (Schulze & Hu, 2005).  
 A more effective way to explain the problem is to define how diabetes affects the adult 
population and the impact toward society in general. The American Diabetes Association (ADA) 
has been actively involved in the development and dissemination of diabetes care standards, 
guidelines, and related documents for over 25 years.  The ADA’s clinical practice 
recommendations are viewed as important resources for health care professionals caring for 
people with diabetes (ADA, 2018). One quarter to one-half of insured patients have an A1C > 
6.0% and many patients are not assessed by primary care providers according to ADA 
guidelines. There are also delays in intensifying treatment, and suboptimal glycemic control. 
This lack of control can lead to clinical complications, such as a 40% increase in the risk of 
microvascular events for each 1% increase in A1C above goal, and a 38% increase in the risk of 
macro vascular events for 1% in A1C above goal (Rowley & Bezold, 2012). There are also 
increased economic burdens to the health care system in general.  
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 The prevalence of Type II diabetes for all age-groups worldwide was estimated to be 
2.8% in 2000 and 4.4% in 2030.  The total number of people with Type II diabetes is projected to 
rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men 
than women, but there are more women with diabetes than men (Wild et al., 2004).  
 In the U.S. the annual projection for adults diagnosed with diabetes incidence will 
increase from about eight cases per 1,000 in 2008 to about 15 in 2050. Assuming low incidence 
and relatively high diabetes mortality, total diabetes prevalence (diagnosed and undiagnosed 
cases) is projected to increase from 14% in 2010 to 21 % of the U.S. adult population by 2050 
(Boyle et al., 2010). An estimated 30.3 million people in the U.S. or 9.4th percentile of the 
population has diabetes, with about one in four people unaware they have the disease. An 
estimated 84.1 million Americans aged 18 years or older have pre-diabetes (NIH, 2017) and it 
may affect between 21% and 33% of the total Unites States population by 2050. The prevalence 
of diabetes in the U.S. is substantial, managing the condition in an effective matter is mandatory 
(Rowley & Bezold, 2012). 
 In Arizona approximately 682,071 people or 12.5% of the adult population have Type II 
diabetes. Of these, an estimated 172,000 have diabetes but are unaware, increasing their related 
health risks. In addition, 1,796,000 people in Arizona or 37.5% of the adult population have pre-
diabetes with blood glucose levels higher than normal but not yet high enough to be diagnosed as 
diabetic. Every year an estimated 34,000 people in Arizona are diagnosed with diabetes. 
Diabetes and pre-diabetes cost an estimated $6.4 billion in Arizona annually (ADA, 2014).  
Purpose and Rationale 
 In every primary care setting there is a large percentage of patients that have been 
diagnosed with Type II diabetes (Renders et al., 2001). As previously mentioned, this problem 
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has been rising. Diet modification as an intervention that helps decrease hemoglobin A1C levels 
should be encouraged to any patient that has poor glycemic control. Diabetes self-management 
education (DSME) is an essential component of care for all people with the condition and is 
necessary to improve patient outcomes and dietary quality (Miller et al., 2012). Prospective 
cohort studies and randomized controlled trials have demonstrated that Type II diabetes can be 
prevented largely through moderate diet and lifestyle modifications (Schulze & Hu, 2005). 
Implementing a diet plan with an emphasis on low calorie foods in a primary care setting could 
benefit those patients that have an elevated hemoglobin A1C > 6 %.  
Background and Significance 
Type II Diabetic Patients 
 Patients with Type II diabetes mellitus are required to perform multiple self-care 
behaviors to achieve and maintain optimal glycemic control (HbA1C), reducing the risks from 
complications and premature mortality (Toobert, Hampson & Glasgow, 2000). Patients with 
diabetes and low socioeconomic status are more likely to have suboptimal A1C, often due to 
non-compliance to recommended self-care activities than their higher socio-economic 
counterparts (Brown et al., 2004). The most important self-care behavior for glycemic control is 
medication adherence (Osborn, Mayberry & Kim, 2016), but lack of resources and poor 
compliance on medication regimen places this population at higher risk to acquire elevated levels 
of A1C and comorbidities related to an uncontrolled glycemic management (cardiovascular 
disease, renal failure, etc.). 
 Gupta, Agarwal and Byadgi (2014) conducted a study on the effects of dietary 
interventions and lifestyle modifications in type two diabetes mellitus patients in India. 
Significant improvement was observed in clinical signs and symptoms along with plasma 
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glucose and glycosylated hemoglobin (A1C) in patients after these interventions (diet change and 
lifestyle modifications). 
Low Calorie Diet and Medication 
 Shiau, So and Dent (2018) conducted a study to examine the outcomes of a low-calorie 
diet and weight management program in Type II diabetic patients. Observed that at six months 
those patients achieved an approximate 16% weight loss. Thirty percent of patients were no 
longer prescribed diabetes medications; and had an insulin discontinuation or decrease of 86.5%. 
Jung and colleagues (2014) conducted a study on the beneficial effects of Korean traditional 
diets in hypertensive and type two diabetic patients, concluding that Korean traditional diets 
(KTD) in contrast to contemporary diets in Korea (control group) for 12 weeks improved blood 
pressure, glycemic control, and cardiovascular risk factors. At the end of the study the KTD 
group had significantly lower anthropometric indicators, including body weight, BMI, body fat 
mass, body fat (%), waist-hip ratio, waist circumference and significantly better hemoglobin 
A1C and heart rate than the control group. 
 Medicare provides a medical nutrition therapy, which is an educational plan available to 
Medicare patients diagnosed with diabetes or renal disease. An initial nutrition and lifestyle 
assessment is performed followed by nutrition counseling (what foods to eat and how to follow 
an individualized diabetic meal plan) and lifestyle factors that affect their diabetes. Follow up 
visits are available to verify patient’s progress in diet and its management (CMS, 2017). This 
educational plan has to be prescribed by the health care provider.  
 In addition, the Community Preventive Services Task Force (organization created by the 
U.S. Department of Health and Human Services) created a fact sheet offering strategies for 
providers to adopt and implement in the local community. The recommendations include 
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administering a combined diet and physical activity program to prevent Type II diabetes for high 
risk individuals (USPSTF, 2017).  
Hemoglobin A1C Levels 
 Glucose and hemoglobin A1C provide complementary information and both are used to 
assess an individual’s glycemic status. The concentration of glucose in the blood indicates the 
subject’s glycaemia at the time of blood sampling. However, blood glucose concentrations are 
modified by numerous factors, ranging from food ingestion and exercise to stress and 
medication. In contrast, the concentration of A1C in the blood reflects the average glucose over 
the preceding eight to twelve weeks. A1C has several attributes which render it valuable in 
assessing diabetes. These include, but are not limited to the following: the patient does not need 
to be fasting, blood can be sampled any time of the day, the sample is stable, and there is very 
little biological variability. These factors in conjunction with the veracity that A1C predicts the 
development of microvascular and macro vascular complications of diabetes have led to the 
widespread adoption of hemoglobin A1C as integral to the management of patients with 
diabetes. Guidelines from several prominent clinical organizations recommend that A1C be 
measured at regular intervals in all patients with Type II diabetes (Sacks, 2012).   
 Diet modifications are important because they contribute to the reduction in hemoglobin 
A1C levels and affect weight management in patients with Type II diabetes. According to Ma et 
al. (2008), dietary management is the cornerstone of care for diabetes, and carbohydrate intake 
has the greatest influence on blood glucose. The study compares different diets and its benefits 
among diabetic patients (Low glycemic index vs. ADA diet). The studies review the benefits of 
diet change and its effect on the reduction of hemoglobin A1C levels. Recommendations vary 
regarding which regimen is better, but most suggest that lifestyle modifications and diet have a 
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strong beneficial impact on the disease. Another randomized control study which focused on a 
low-fat vegan diet and its benefits for Type II diabetic patients concluded that a low-fat vegan 
diet improved glycemic and lipid control better than an ADA diet (Barnard et al., 2006). 
Internal Evidence 
 Healthcare providers in a primary care clinic in southern Arizona currently follow the 
Comprehensive Type II Diabetes Management Algorithm (Nathan et al., 2009) and recommend 
lifestyle modifications to manage the disease, but a specific diet low in calories is not formally 
prescribed.  
PICOT Question 
 This inquiry has led to the clinically relevant PICOT question, “In diabetic patients Type 
II with a hemoglobin A1C > 6.0% (P), how does the combination of a low calorie diet and 
medication regimen (I) compared to a medication regimen only (C) affect their hemoglobin A1C 
levels (O) over a two-month period (T)?” 
Search Strategy 
 An exhaustive search of the literature was conducted using the following databases: 
Cumulative Index of Nursing and Allied Health Literature (CINAHL), PubMed, and ProQuest. 
Keywords included: effects of diet, diabetic patients, how to reduce, hemoglobin, impact of diet, 
diabetes type 2, low calorie diet, a1c, hemoglobin a1c, diet, how diet affects, medication 
management, adult, medication. The initial search in CINAHL produced 1,488 results, the words 
used were diabetes, diet and hemoglobin (Appendix A). The searched in PubMed yielded 2200 
results on the first search, the terms used were diabetes type 2, hemoglobin a1c, diet and adult. 
(Appendix B). When ProQuest was searched using the words diabetes type 2, hemoglobin a1c 
and adults, 6,754 results showed in the database (Appendix C). By making the search more 
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specific to the terms related to the PICOT question and by combining them to include all the 
components, the final search included all the terms related to the PICOT question, resulting in a 
final yield of 97 studies in CINAHL (Appendix A), 85 studies in PubMed (Appendix B) and 
1386 in ProQuest (Appendix C). An additional search strategy was performed using Cumulative 
Index of Nursing and Allied Health Literature (CINAHL). Keywords included: diabetes type 
two, diet, Hispanic, Latino, hemoglobin A1C. The initial search produced 3, 398 results 
(Appendix D).  By making the search more defined the final yield resulted in 76 studies with the 
latest terms.  
 Studies published prior to 2012 were eliminated as part of the exclusion criteria, with a 
single exception of one study because of its statistical relevance. Andrews et al. (2011) is a 
multicenter parallel group randomized control with a large sample size (n-593) and statistically 
significant (A1C levels p<0.005 after 12 months of treatment). Those involving children, 
adolescents, type one diabetes and adults in an intensive care unit, were also excluded. 
 After appraising 38 studies ten have been chosen for inclusion in this literature review. 
The included studies comprise the relationship between diabetes type two, elevated hemoglobin 
A1C, diets low in calories, adults, medication regimen and the effects of diet in the management 
of diabetes type two (Appendix E). After an exhaustive additional search for studies that parallel 
the goals of the proposed project, three more studies were found and added to the original ten 
previously chosen to guide the project. 
Critical Appraisal and Evidence Synthesis 
 Ten studies included in the literature review were subjected to rapid critical appraisal and 
found to sufficiently address the elements of the PICOT question. Melnyk and Fineout-
Overholt’s (2015) hierarchy of evidence rating system was used to evaluate the level of evidence 
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of each study, Andrews et al. (2011) a multicenter parallel group randomized controlled study 
provided level II evidence. Coppell et al. (2017) a mixed methods non-randomized quantitative 
and qualitative pilot study provided level III evidence. Johansen et al. (2017) a randomized 
clinical trial provided level II evidence. Jung et al. (2014) a randomized controlled trial provided 
level II evidence. Rock et al. (2014) a randomized controlled trial provided level II evidence. 
Sylvetsk et al. (2017) a multicenter randomized controlled clinical trial provided level II evidence 
and Wolever et al. (2017) a randomized controlled trial provided level II evidence.  
For the multicenter randomized controlled trial (RCT), mean HbA1C concentrations were 
significantly lower at six and 12 months in patients who received either study intervention than 
in those who received usual care, effect sizes were 0.3 SDs, and the lower 95% Cl values were 
roughly equivalent to the specified target difference of -0.5% (Andrews et al., 2011). One was a 
mixed-methods non-randomized quantitative and qualitative study, and five were randomized 
control trials. Of the three remaining studies one consisted on a trial clinical prospective and 
interventional study (level IV evidence), the second one consisted on a weighted linear 
regression with the use of cross-sectional data (level V evidence), and the last one was a 
retrospective cohort study (level IV evidence). Additionally, three studies had been added to the 
original ten. The first study (Cubillos, et al., 2017) consists of a clinical pilot (level III evidence), 
which was conducted in two phases (a formative and a clinical pilot).  
Adherence to a Mediterranean diet increased from 5.7 to 7.9 for a difference of 2.3 (95% 
Cl, 1.0-3.5), p = .001. The second study -PREDIMED- (Estruch, et al., 2013) is a randomized 
controlled trial (level I evidence) where 7447 participants were enrolled. The study was 
conducted in Spain to demonstrate the relationship between a Mediterranean diet supplemented 
with extra-virgin olive oil or nuts and the reduction of major cardiovascular events. After the first 
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follow up year, mean scores of adherence to the Mediterranean diet were significantly higher in 
the two Mediterranean diet groups than in the control diet group (p < 0.001 for all yearly 
comparisons from year one to six of follow-up). The third article relates to the 14-Item 
Mediterranean Diet Assessment Tool utilized on the PREDIMED Trial (level III evidence). This 
is a cross-sectional assessment of all participants in the PREDIMED trial. The study showed that 
high consumption of nuts and low consumption of sweetened/carbonated beverages presented 
the strongest inverse associations with abdominal obesity. The 14-Item Tool was able to capture 
a strong monotonic inverse association between adherence to a good quality dietary pattern 
(Mediterranean diet) and obesity indexes in a population of adults at high cardiovascular risk 
(Martinez-Gonzalez, et al., 2012). 
 Some bias was present across studies, Andrews et al. (2011) reports to be an independent 
consultant for four pharmaceutical companies. Coppell et al. (2017) excluded patients that do not 
speak English. Darwiche et al. (2016) excluded patients from different ethnicities and Kollanoor-
Samuel et al. (2016) also excluded patients from other ethnic groups. Two studies were financed 
by private industry. One study was financed by Jenny Craig, researchers controlled only a 
portion of the study data management, analysis and publication (Rock et al., 2014). Wolever and 
colleagues (2017) are partial owners of Glycemic Index Laboratories and is an independent 
consultant for various other laboratory companies.   
 The sample sizes were adequate except for Darwiche (2016) and Jung (2014), whose 
sample sizes were small. Additionally, there was a considerable degree of heterogeneity in the 
sample demographics consisting of different cultures, ages, and ethnicities with the exception of 
a few studies whose primary focus was on certain populations. The sample sizes were 
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homogeneous in that most of the samples consisted of patients older than 18 years of age with an 
elevated hemoglobin A1C, diabetic or pre-diabetic diagnosis and elevated BMI.  
 There was moderate homogeneity in the independent variables in terms that the majority 
focused on diet and physical activity. But there was more heterogeneity in the dependent 
variables. Some concentrated their attention only on A1C levels and weight, while others made 
emphasis on insulin resistance, blood pressure, BMI, health-related quality of life activities and 
glucose lowering medications among others. The majority of the studies used similar 
measurement tools, for example to obtain blood samples the participants went to a laboratory 
were standard technique was used to draw their blood. To measure their height and weight a 
standard scale was utilized, and to take their blood pressure standard technique was also used. Of 
the ten studies six demonstrated statistically significant positive associations between A1C levels 
and diet, specifically when pre-diabetic or diabetic patients follow a diet that focuses on 
decreasing hemoglobin A1C levels. Seven of the ten studies demonstrated statistically significant 
positive associations between weight loss and diet. Statistically significant results (A1C levels 
and weight) and quality measurement tools and instruments suggest strong validity and reliability 
across the studies (Appendix E). 
Discussion 
 The studies reviewed suggest that the implementation of a diet low in calories, 
carbohydrates and/or fat improves A1C levels and assists with weight management (decreasing 
weight, reducing BMI levels, reducing A1C levels). The evidence reviewed suggests that when a 
diet low in calories is added into the plan of care of a diabetic patient his or her anthropometric 
measures significantly improve (p<0.001) (Coppell et al., 2017). Lifestyle modifications (aerobic 
training sessions) led to a substantial and parallel reduction in glucose lowering medication 
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(Johansen et al., 2017). The findings of another study suggest that diet alone (Korean traditional 
diet) had significant effects on body weight, BMI, body fat mass, body fat (%), A1C levels and 
heart rate. Resulting in favorable changes in glycemic control, body composition, and 
cardiovascular risk factors (Jung et al., 2014). Based on the evidence, providers could implement 
diet changes on pre-diabetic and diabetic patients that have poor glycemic control, elevated 
hemoglobin A1C and elevated BMI. The variety of diets presented in the studies (Appendix F) 
offer providers the option to choose the dietary plan that best fits the needs of their patients. 
Based on the evidence reviewed hemoglobin A1C and weight were consistent outcome 
measurements.  
The findings of the randomized controlled trial (Estruch, et al., 2013) that took place in 
Navarra, Spain showed the prevalence of diabetes and current smoking were lower among 
participants with higher adherence to the Mediterranean diet (Martinez-Gonzalez, et al., 2012). 
Utility of Evidence 
 The evidence presented by Cubillos, et al. (2017), Estruch, et al. (2013) and Martinez-
Gonzalez, et al. (2012) supported the implementation of a diet program based on the 
Mediterranean diet that was culturally acceptable for Hispanic American patients who have been 
diagnosed with Type II diabetes. 
 After multiple meetings with the lead provider of the clinic, it was recommended to 
formally implement the Mediterranean diet for all those patients that had a hemoglobin A1C > 6 
% for a period of eight weeks. The implementation of the Mediterranean diet for Type II diabetic 
patients at a clinic in Southern Arizona could decrease hemoglobin A1C levels, reduce weight 
and improve quality of life. The ethnicity of the patients who visit the clinic are mostly Hispanic, 
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implementing a diet that includes foods that are part of their daily eating habits increases diet 
adherence (Estruch at al., 2013). 
Theoretical Models 
 An evidence based practice model and a nursing health promotion model were selected to 
guide the overall project process and the specific nursing intervention. 
Evidence-based Process Model 
 The Rosswurm and Larrabee model (Rosswurm & Larrabee, 1999) is derived from 
theoretical and research literature related to evidence-based practice, research utilization, and 
change theory. The model guides practitioners through the entire process of changing to 
evidence-based practice, beginning with the assessment of the need for change and ending with 
the integration of an evidence-based protocol. The model is suitable to be used in primary care or 
other settings in addition to acute inpatient units. This model guided the implementation of the 
project (diet implementation to decrease hemoglobin A1C levels) by assisting the doctoral 
student to assess the need for change in practice, link the problem to interventions and outcomes, 
synthesize the best evidence, design the practice change, implement and evaluate change in 
practice and integrate and maintain change in practice (Appendix G). 
The implementation of the intervention followed step four “Design-practice change” of 
the evidence-based model of Rosswurm & Larrabee, which consists of identifying the needed 
resources, the plan implementation process, and the definition of outcomes. Pender’s Health 
Promotion Model guided the proposed intervention encouraging the individual to modify his or 
her diet and to commit to a plan of action that will lead to a health promoting behavior (diet 
modification). The evidence enabled the writer to decide what outcome variables were measured 
for the project. The recommended outcomes were hemoglobin A1C levels, body weight and diet 
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adherence. At both the beginning and the end of the project the dependent variables (A1C, body 
weight and diet adherence) were measured to verify the feasibility of the intervention (diet 
modification). 
Health Promotion Model 
 The Pender’ Health Promotion Model (Khodaveisi, Omidi, Farokhy & Soltaninan, 2017) 
guided the intervention. The model presents a systematic way of understanding events, behaviors 
and situations. Within the model there are several concepts that allow the provider to understand 
at what stage the patient is and if he or she perceives the benefits, barriers, behavior-related 
affect (positive or negative), self-efficacy and situational influences on their current condition. It 
also assists the provider and patient to understand their prior related behaviors and personal 
factors (lack of exercise, diet high in calories and carbohydrates, genetics) and how these factors 
have a strong influence on their weight, A1C levels, and current medical condition (Type II 
diabetes) (Appendix H). 
 The model addresses significance of motivation which is modifiable through both actions 
and the perceived benefits of action. Applied to this project, patients can achieve motivation thru: 
weight loss, decrease in A1C levels and better management of their Type II diabetes. The model 
also includes the perceived barriers to action, in this project considerations could be: difficult 
with change (a new diet is challenging), perceived self-efficacy (I cannot do this), activity-
related affect, (this makes me unhappy), interpersonal influences (I do not have support at 
home), and situational influences (I cannot take my lunch to work, I do not have time to do this). 
Setting the Stage/Plan 
 The project plan to introduce a Mediterranean diet to the targeted patients required the 
buy-in and involvement of clinic stakeholders (providers, patients, administration, medical 
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assistants and phlebotomists). The proposed patient education materials, flyers and guidelines 
were introduced to the stakeholders, resulting in consensus for their use at the clinic. 
Outcome Measurement Tool 
 The 14-Item Mediterranean Assessment Tool (Appendix I) was selected to measure 
patient’s adherence for pre and post diet intervention and was used in a face-to-face interview 
with each participant. The 14-item tool was developed in a Spanish case-control study 
(PREDIMED) of myocardial infarction, where the best cut-off points for discriminating between 
cases and controls were selected for each food or food group (Martinez-Gonzalez et al., 2012). 
The tool was chosen because the questionnaire captured a strong monotonic inverse association 
between adherence to a good quality dietary pattern (Mediterranean diet) and obesity indexes in 
a population of adults at a high cardiovascular risk (Martinez-Gonzalez et al., 2012) 
 Validity and reliability. In the validation study (Martinez-Gonzalez et al., 2012), the 
score obtained with brief 14-item questionnaire correlated significantly with that obtained from 
the full-length 137-item (FFQ) score (Pearson correlation coefficient (r) = 0.52; intra-class 
correlation coefficient = 0.51). Significant inverse correlations of the 14-item tool with fasting 
glucose, total: HDL cholesterol ratio, triglycerides and the 10-y estimated coronary artery disease 
risk also supported the validity of this brief Mediterranean diet adherence screener (Martinez-
Gonzalez et al., 2012). Permission to use the tool was obtained from the author. 
Project Methods 
 The clinic provided a letter indicating permission to implement the project at the clinic.  
The Institutional Review Board (IRB) at Arizona State University approved the study on 
7/20/2018 (Appendix J). The protection of human subjects was of relevant importance for the 
evidence-based practice project. Patient’s privacy interests were protected and only their 
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provider, medical assistants, phlebotomy and doctoral student had access to their electronic 
medical record (EMR). Charts were reviewed to identify those patients that qualified for 
participation in the project. All the participants that qualified for the project had the same 
provider (Family Nurse Practitioner). The setting for the project took placed in a primary care 
clinic located in Southern Arizona.  
Budget 
The project was entirely funded by the doctoral student (one-liter bottle of olive oil, one 
pound of nuts and a $10.00 gift card from Sprouts was provided to each participant that agreed to 
participate in the project). The total cost of the project was $995.00. 
Sample 
 Patients previously identified as Type II diabetics with an elevated hemoglobin A1C > 
6.0 were recruited for the project during the months of September and October of 2018 during 
their scheduled appointments.   
 Informed consent. Patients were notified that their participation would involve two (20 
minutes) educational sessions at the clinic following their usual scheduled appointments and two 
(5-15 minutes) phone conversations to review their progress (date and time was determined by 
each participant). The study also entailed a completion of a pre and post-questionnaire (14-Item 
Mediterranean Assessment tool) and a demographics questionnaire (26 questions-five minutes to 
complete) (Appendix K) on visit one which was repeated on follow up visit two (14 questions to 
complete) during their usual scheduled appointment. Participants were notified that data would 
be taken from their medical record (weight and hemoglobin A1C) for study use to measure 
outcome of diet. The pre and post study questionnaire was used to determine if the information 
DIET MODIFICATION IN TYPE II DIABETIC PATIENTS  18 
modified their diet.  Participants were also notified that the study needed to be completed within 
two months and each session and questionnaire would be individually linked.  
Individuals were aware that their participation in the study was voluntary and that each 
participant needed to be 18 years or older to be eligible. They were also notified that they would 
not incur a penalty if they chose not to participate or to withdraw from the study at any time. The 
intervention was free to each participant, and routinely collected lab results at the time of the 
visit were used.  Educational materials were developed in two languages (English and Spanish), 
and were translated by the doctoral student. 
Benefits for participation included increased knowledge of the Mediterranean diet, 
potential weight loss, and potential decrease on hemoglobin A1C level. Participants received a 
bottle of olive oil (visit one), a bag of nuts (almonds or walnuts) and a $10.00 Sprouts gift card 
(visit two) upon completion of the study. 
Intervention 
The measurement outcomes were: hemoglobin A1C, weight and diet adherence. Each 
participant received the following educational materials: 14-Item Mediterranean questionnaire, 
dietary goal (Appendix L), informational flyer (Appendix M) and Mediterranean diet guidelines 
(Appendix N). During the months of September through the first week of December, data was 
collected (consents of participation, questionnaires, pre and post weight and hemoglobin A1C) 
by the medical assistants and doctoral student. During the months of January through March 
2019, data was entered into SPSS.  
The first week of the project recruitment took place at the clinic. Informational flyers 
were posted in the waiting room for all patients to see. Interested and eligible participants were 
contacted by phone or in person (at site) by the DNP student. As required, written informed 
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consent (Appendix O) was obtained from those eligible individuals. Measurements were taken 
by the medical assistants and phlebotomists (weight and hemoglobin A1C) and were recorded on 
each individual’s electronic medical record. The 14-Item Mediterranean Diet Assessment Tool 
was provided by the DNP student while an overview of the program and the timeline of the 
intervention (Appendix P) was explained to each individual who agreed to participate in the 
project. Two sessions in person as well as two phone calls were part of the intervention, with the 
ultimate goal to educate each participant on the guidelines of the Mediterranean diet and to 
review each participant’s dietary goals. Educative materials were provided in session one as well 
as a one-liter bottle of olive oil and a $10.00 gift card from Sprouts. During the second on site 
visit, guidelines and goals were reviewed with each participant. Weight, hemoglobin A1C and 
14-Item Mediterranean Diet Assessment Tool were also recorded on all participants. Each 
individual received a one pound of nuts (almonds or walnuts) during visit two. Outcomes of the 
intervention (hemoglobin A1C, weight and results of the 14-Item Mediterranean Diet 
Assessment Tool) were reviewed with each individual during their follow up appointment at the 
clinic. 
Outcomes/Project Results 
 The sample consisted of 27 participants (adult males and females). 23 participants had 
their weight measured post intervention. Of the 27 participants, 14 completed the diet adherence 
questionnaire. The hemoglobin A1C value was collected on 12 participants post intervention due 
to medical insurance denial of coverage for the test. A paired sample t-test was used, also called 
a dependent t test, which compares the means of two scores from related samples. Comparing a 
pre-test and a post-test score for a group of participants requires a paired-samples t test according 
to Cronk (2014).  
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 A paired-samples t test was calculated to compare the mean pre-adherence score to the 
mean post-adherence score. The mean on the pre-adherence was 4.29 (sd = 1.54), and the mean 
on the post-adherence was 7.21 (sd = 1.31). A significant increase from pre-adherence to post-
adherence was found (t(13) = - 7.346, p < .001). 
These results suggest that educating patients on a specific intervention (Mediterranean 
diet) and following up after implementing the intervention had a positive effect in diet adherence 
(Mediterranean diet).  
It is relevant to report that the results pertinent to weight loss were not statistically 
significant. A paired-sample t test was calculated to compare the mean pre-weight score to the 
mean post-weight score. The mean on the pre-weight was 204.20 (sd = 73.58), and the mean on 
the post-weight was 203.93 (sd = 73.59). No significant difference from pre-weight to post- 
weight was found (t(22) = .171, p > .05). 
These results suggest that a diet intervention performed in eight weeks does not reflect a 
significant weight loss among participants. For future research a longer intervention is needed to 
verify the effectiveness of the Mediterranean diet in weight loss.  
The result of the scores of the hemoglobin A1C value were also not significant. A paired-
sample t test was calculated to compare the mean pre-hemoglobin A1C score to the mean post- 
hemoglobin A1C score. The mean on the pre-A1C was 7.00 (sd = 1.32), and the mean on the 
post-A1C was 6.82 (sd = 1.44). No significant difference from pre-A1C to post-A1C was found 
(t(11) =.815, p > .05).  
These results also suggest that a longer intervention is needed (> 3-4 months) to allow 
time for changes in hemoglobin A1C and weight management. Due to lack of insurance’s 
DIET MODIFICATION IN TYPE II DIABETIC PATIENTS  21 
approval 15 participants were not able to measure their levels of hemoglobin A1C, which 
affected the tests results. 
Discussion 
 The clinic has a high percentage of Type II diabetic patients that have poorly controlled 
diabetes presenting with symptoms including: elevated A1C levels, poor compliance, elevated 
BMI, and comorbidities related to diabetes.  
Implications 
If the clinic’s stakeholders decide to implement educational measures to teach each Type 
II diabetic patient the benefits of a diet (Mediterranean diet) and lifestyle modifications, 
hyperglycemia will improve as well as weight management. Providers will be able to measure 
the tangible benefits that a change of diet implies to a diabetic patient (A1C levels and weight). 
A1C and weight should continue to be measured every three months to verify patient’s 
improvement. Compliance among patients may improve when they experience the benefits of 
losing weight, being able to exercise, and enhancement of their quality of life. The project 
outcomes were the reduction on A1C levels, weight loss and diet adherence. The strengths of the 
project were the educational sessions that each participant received (educational flyers, dietary 
goals and Mediterranean guidelines). Diet adherence increased and the majority of the 
participants verbalized an understanding of how a change in lifestyle is needed to improve their 
hemoglobin A1C and weight control.  
Sustainability 
 Sustainability will require the ongoing support from stakeholders and the need for future 
partnerships with diabetes educators for continuous education. Currently the clinic has a diabetic 
educator that provides monthly educative classes to every diabetic patient that agrees to assist on 
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the first Wednesday of the month. The classes focus on diet management and medication usage. 
To sustain this project, will be important to educate staff members (providers and medical 
assistants) as staff champions to implement the intervention (Mediterranean diet) in a weekly 
basis and sustain it for at least six months to accurately measure outcomes (weight, hemoglobin 
A1C and diet adherence). 
 Future research should focus on the benefits that the Mediterranean diet provides to Type 
II diabetic patients and how this dietary change can improve their weight and hemoglobin A1C 
levels. One provider is interested in continuing the intervention with her diabetic patients. The 
educational materials were given to the office manager and providers for the future 
implementation of the project. Actual outcomes might change within time (three to four months) 
post intervention. 
Project Limitations and Barriers 
 The limitations of the project are related to the time of the intervention (eight-weeks). At 
least three to four months are needed to verify the significance of the evidence-based practice 
project. Unforeseen barriers included insurance approval, collecting data during three holidays 
(Halloween, Day of the Dead and Thanksgiving) that characteristically include high calorie 
traditional Mexican and American foods that have elevated content of carbohydrates. 
Participants admitted that following a diet during the holiday season was challenging. 
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Conclusion 
 The project confirmed that the establishment of educational programs oriented to modify 
lifestyle (diet) are effective in a primary care setting. As a future family nurse practitioner and 
doctoral student, the writer learned that implementing an intervention in a primary care setting is 
challenging and requires constant effort not only from the primary investigator but from the staff 
in general. Motivation, encouragement and evidence-based practice interventions are mandatory 
to sustain a project that modifies patient’s behaviors. 
 To obtain better results the writer would extend the intervention to three to four months 
instead of eight weeks and will choose a different season of the year where the participants tend 
to be more receptive and motivated to lose weight and change their eating habits.    
 The entirety of the DNP 712 classes prepared the doctoral student to implement this 
project from beginning to end. Phase I (approval from IRB, site, and instruments) was primarily 
challenging because continuous correction needed to be done in order for the project to start, but 
the implementation phase was very encouraging as the excitement of the staff and the 
participants towards the intervention was evident. 
 This evidence-based project allowed the writer to become more independent in a foreign 
setting and to learn how to motivate and implement an intervention that required a change in 
behavior from each participant. Educating patients on a weekly basis not only allowed the writer 
to establish appropriate rapport with the participants, but after the second session the student and 
patients felt more comfortable with each other, enabling the student to grew as an educator and 
future practitioner through this experience. 
 As a result, the participants acquired knowledge of the Mediterranean diet and its 
benefits. Even though their hemoglobin A1C and weight did not show significant difference, 
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their diet adherence motivated them to continue with a lifestyle change that in the long term will 
modify their outcomes. The clinic kept all the educative materials and in the near future plans to 
continue with the project. The awareness that the project brought to the clinic regarding the 
elevated incidence of Type II diabetes among their clients will benefit their practice. 
 The following DNP essentials that were met by the DNP student are: systems thinking, 
health organizations, and the advanced practice nurse (APN) leader. This project allowed the 
student to practice policies and procedures in meeting the health needs of the patient populations 
with whom the writer practiced. It also allowed the student to create an intervention and 
strategies that will sustain changes in an organization for the near future (Zaccagnini & White, 
2014).   
 Information systems technology and patient care for the improvement and transformation 
of health care was another essential that was covered during the implementation phase of this 
project. Computer literacy and competency were essential for the execution of this project. The 
student needed to constantly access the electronic medical record of each participant for 
information retrieval. The use of statistical software (SPSS) was mandatory for data entry, 
statistical information and testing. 
 Interprofessional collaboration for improving patient and population health was another 
DNP essential covered by the doctoral student. Constant communication and exchange of 
information was a daily practice during the execution of the project and the continuous 
interaction between the doctoral student and the stakeholders was necessary for the success of 
the project and the provision of care towards the participants. 
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 As a result of this implementation the student and the staff developed a collaborative 
relationship that benefited not only their patients, but the DNP student, as valuable lessons were 
learned from this intervention.  
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Appendix A 
 
Figure 1.1. Screenshot of Database Searched, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) 
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Appendix B 
 
Figure 1.1. Screenshot of Database Searched, PubMed 
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Appendix C 
 
Figure 1.1. Screenshot of Database Searched, ProQuest Dissertation  
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Appendix D 
 
Figure 1.1. Screenshot of Database Searched, CINAHL 
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Appendix E Quantitative Studies 
Table 1 
Evaluation Table 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major 
Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Andrews et al. 
(2011) 
Diet or diet plus 
physical activity 
versus usual care 
in patients with 
newly diagnosed 
type 2 diabetes: 
The Early ACTID 
randomized 
controlled trial. 
 
Country: 
England 
 
Funding: 
Diabetes UK and 
the UK 
Department of 
Health 
 
Bias: 
RCA (honoraria 
from GSK, NN, 
SA and Lilly). 
CMD (Consulter 
fees from GSK and 
Medtronic). 
Physiologic 
Model 
explaining 
the benefits 
of diet and 
physical 
activity to 
improve 
outcomes on 
diabetic 
patients. 
Design: 
Multicenter parallel- 
group, randomized 
controlled. 
 
Purpose: 
To evaluate the 
effectiveness of 
increase physical 
activity and diet 
intervention. 
N-8 studies 
n- 593 
 
CG- 99 
IG1- 248 
IG2- 246 
 
At 6 months: 
n- 587 
CG- 97 
IG1- 247 
IG2- 243 
 
At 12 months 
n- 579 
CG- 93 
IG1- 246 
IG2- 240 
 
Demographics: 
Males and 
females > 30 
years old. 
 
Setting: 
Southwest 
England 
 
Inclusion: 
IV1- Diet 
IV2 – 
physical 
activity 
 
DV1- A1C 
DV2 – Body 
weight 
DV3-insulin 
resistance 
DV4- BP 
 
Time frame 
of the 
intervention: 
6 and 12 
months 
 
 
IV 1-Diabetes 
UK dietary 
guidelines. 
 
DV1-
performed in 
laboratory 
using standard 
technique. 
 
DV2- 
“measured 
according to 
standard 
procedure” 
 
DV3-measured 
by homeostasis 
model 
assessment. 
 
DV4- not 
stated on the 
study. 
 
Descriptive 
statistics, 
multivariable 
linear 
regression 
with 
Bonferroni 
correction.  
At 6 months: 
 
DV1- A1C -
0.28% (-0.46 
to -0.10) p< 
0.0049 
 
 
At 12 months: 
 
DV1-A1C -
0.26%(-0.44 to 
-0.08) p< 
0.005 
 
 
 
 
  
Level II, 
 
Strengths 
Community-based 
recruitment, the 
targeting of newly 
diagnosed 
individuals, the 
matching of 
contact time for 
the two study 
interventions and 
the use of 
motivation-based 
lifestyle programs 
without direct 
supervision that 
could be 
transferred into 
primary care at 
little cost. 
 
Weaknesses 
The additional 
activity program 
did not further 
improve 
outcomes, further 
research is needed 
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Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major 
Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Older than 30 
years old, newly 
diagnosed with 
type 2 diabetes. 
 
Exclusion: 
Older than 80 
years, Ha1c > 
10%, BP > 
180/100, LDL 
cholesterol > 
4mmol/I., BMI < 
25, weight > 180 
kg, use of weight 
loss drugs, taking 
a sulphonylurea 
at the maximum 
dose, unstable 
angina, an MI 
within the 
previous 3 
months, unable to 
increase physical 
activity, and 
pregnancy or 
planning to 
become pregnant.  
 
Attrition: 
14 (2.4%). 
 
 
 
 
 
to clarify whether 
different 
programs or 
intensities of 
physical activity, 
longer 
interventions, or 
intervention at an 
earlier or later 
stage of diabetes 
will have benefits 
additive to those 
of dietary 
modification. 
 
Conclusions: 
The study clearly 
reflects the 
benefits of diet 
implementation 
on diabetic 
patients and its 
impact on their 
hemoglobin A1C 
(decrease). 
 
Feasibility: 
Recommended to 
use in practice 
due to the 
effectiveness of a 
lifestyle-based 
program among 
diabetic patients. 
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Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major 
Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
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Findings/ 
Results 
Level/Quality of 
Evidence; 
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practice/ 
application to 
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Coppell et al. 
(2017) 
The effectiveness 
of a primary care 
nursing led dietary 
intervention for 
pre-diabetes: A 
mixed methods 
pilot study. 
 
Country: 
New Zealand 
 
Funding: 
The New Zealand 
Ministry of Health, 
a Hawke’s Bay 
Medical Research 
Foundation grant 
in aid and a New 
Zealand Society 
for the Study of 
Diabetes research 
award.  
 
Bias: 
Selection bias 
(Excluded patients 
that do not speak 
English) 
Physiologic 
Model that 
explains the 
benefits of 
dietary 
implementati
on in pre-
diabetic 
patients. 
Design: 
Mixed methods Non-
randomized 
quantitative pilot study 
and qualitative. 
 
Purpose: 
To evaluate the 
effectiveness of a 
structured pre-diabetes 
dietary intervention 
led by primary care 
nurses. 
n- 133 
IG-67 
CG-66 
 
Demographics: 
Aged < 70 years  
English speakers 
Males and 
females 
 
Setting: 
Primary care 
setting, 
community 
settings. 
 
Inclusion: 
Non pregnant 
adults 
Aged < 70 years 
with newly 
diagnosed pre-
diabetes with an 
A1C 6.1-6.9. 
BMI > 25, not 
prescribed 
Metformin. 
 
Exclusion: 
Non English 
speakers,  
Pregnancy, adults 
> 70 years of age, 
BMI < 25. 
IV- diet 
intervention 
 
DV1- weight 
DV2- A1C 
 
Time frame 
of the 
intervention: 
6 months. 
IV1- Diet 
Diabetes and 
Healthy Food 
Choices-New 
Zealand. 
 
DV1- standard 
practice for 
weight 
measurement 
(weighing 
scales, shoes 
were removed, 
and patients 
were wearing 
only one layer 
of light 
clothing) 
nurses took 
duplicate 
measures to 
verify accuracy 
of information. 
 
DV2- A1C 
levels were 
collected at the 
laboratory by 
the nurse. 
Chi-squared 
and Fisher’s 
Exact tests.  
Linear 
regression 
models.  
 
At 6 months: 
 
DV1- Weight- 
(SD) 95.6 
(23.8), ratio 
0.97 (0.95, 
0.98) p< 0.001 
 
DV2- A1C- 
(SD) 42.0 
(3.6), ratio 
0.96 (0.92, 
1.00) 
p 0.096 (not 
significant) 
Level III 
 
Strengths: 
Although mean 
weight loss was 
relatively small, it 
is clinically 
meaningful, as in 
the decrease for 
each kilogram the 
risk of 
progressing to 
diabetes was 
reduced by 16%. 
 
Weaknesses: 
The less than 
expected mean 
weight loss and 
insignificant 
change in HbA1c 
may reflect 
insufficient 
intensity of the 
intervention as 
both nurses and 
patients 
recommended 
additional 
sessions or 
monthly phone 
check-ins. 
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Taking 
Metformin. 
Already 
discussed pre-
diabetes 
management. 
 
Attrition: 
24 (15.28%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions: 
Even though there 
is no significant 
difference on the 
A1C level, there 
are significant 
improvements on 
anthropometric 
measures (weight 
p< 0.05). 
 
Feasibility: 
Recommended to 
use in practice. 
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Cubillos et al. 
(2017) Feasibility 
and acceptability 
of a clinic-based 
Mediterranean 
style diet 
intervention to 
reduce 
cardiovascular risk 
for Hispanic 
Americans with 
Type 2 diabetes. 
 
Country: 
United States 
 
Funding: 
The research was 
supported by Grant 
No. P30DK093002 
from the National 
Institute of 
Diabetes and 
Digestive and 
Kidney Diseases. 
University of 
North Carolina at 
Chapel Hill. 
 
Bias: 
Preferred patients 
that are of 
Hispanic descent. 
Physiologic 
Model that 
explains the 
benefits of 
adherence 
diet to a 
Mediterrane
an style diet 
intervention. 
Pilot study 
 
Purpose: 
To modify a 
previously tested 
Spanish language 
version of a 
Mediterranean style 
dietary intervention so 
that the dietary 
recommendations 
align with the cultural 
and social needs of 
Hispanic Americans 
with type 2 diabetes 
and evaluate the 
modified 
intervention’s 
feasibility and 
acceptability. 
n= 19 
IG= 19 
 
Demographics: 
Male, females, 
from Mexico, 
Central America 
and South 
America. 
Hispanic 
participants with 
diabetes type 2. 
Spanish language 
preference. 
 
Setting: 
The University of 
North Carolina, 
Chapel Hill. 
 
Inclusion: 
Diabetes type 2, 
cardiovascular 
disease, male, 
female, adult, 
Spanish speaking. 
 
Exclusion: 
Kidney disease, 
cancer, pregnancy 
or planning to 
become pregnant 
in the next 6 
months, or a 
IV- 
Mediterranea
n diet 
 
DV1- Diet 
adherence 
 
DV2- Weight 
 
DV3- A1C 
 
Time frame 
of the 
intervention: 
 
2 months. 
IV1- Four 
counseling 
sessions. 
 
DV1- 14-Item 
PREDIMED 
dietary 
screener. 
 
DV2-electronic 
scale (Scale-
Tronix, 
Skaneateles 
Falls, New 
York) 
 
DV3- Assessed 
by the hospital 
clinical 
laboratory. 
 
Descriptive 
statistics were 
used to 
describe 
baseline 
demographic 
and health 
characteristics
, and 95% 
confidence 
intervals are 
reported for 
change in pre-
post 
measures. 
Statistical 
analyses were 
performed 
with Stata 
software. 
At 2 months: 
 
DV1-(95% Cl, 
1.0-3.5) 
p=.001 
 
DV2- Weight 
0.0 (-0.5 to 
0.5) p=.99 
 
DV3- A1C 0.3 
(0.0 to 0.6) 
p=.07 
Level III 
 
The En Forma-
Diabetes adapted 
dietary 
intervention 
proved to be 
feasible and 
acceptable to 
study participants.  
 
Overall, the 
retention and 
completion rates 
were high for all 
study 
components. 
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serious medical 
condition.  
 
Attrition: 
2 (9.53%) 
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Darwiche et al. 
(2016) 
An Okinawan-
based Nordic diet 
improves 
anthropometry, 
metabolic control, 
and health-related 
quality of life in 
Scandinavian 
patients with type 
2 diabetes: A pilot 
trial 
 
Country: 
Sweden 
 
Funding: 
Grants from Hans-
Gabriel and Alice 
Trolle 
Wachtmeister’s 
Foundation for 
Medical Research, 
King Gustaf and 
Queen Victoria 
Free Maison’s 
Foundation, Dir 
Albert Pahlsson’s 
Foundation, 
Development 
Foundation of 
Region Skane, and 
Foundation of 
Health 
Belief 
Model 
Design: 
Trial clinical 
prospective study-
prospective 
interventional study. 
 
 
Purpose: 
To evaluate the 
effectiveness of an 
Okinawan-Nordic diet 
in Scandinavian type 2 
diabetic patients. 
 
n- 28 
IG- 28 
 
Demographics: 
Scandinavian 
males and 
females with both 
parents inborn in 
Scandinavia. 
Aged between 18 
and 70. 
 
Setting: 
Primary health 
care center in 
southern Sweden. 
 
Inclusion: 
Both parents 
inborn in 
Scandinavia. 
Ages 18-70-year-
old. 
 
Exclusion: 
Not 
Scandinavian, 
severe food 
allergy, type 1 
diabetes, major 
gastrointestinal 
surgery; severe 
heart, pulmonary, 
cardiovascular, 
malignant, or 
IV- 
Okinawan-
based Nordic 
diet 
 
DV1- BMI 
 
DV2- A1C 
 
DV3- health-
related quality 
of life 
(physical 
functioning) 
 
Time frame 
of the 
intervention: 
12 weeks 
 
IV1- Diet- 
Okinawan-
based Nordic 
diet 
 
DV1- Height 
was measured 
to the nearest 
centimeter, and 
weight to the 
nearest 
kilogram in 
subjects 
wearing light 
clothes, but not 
shoes, and 
BMI was 
calculated.  
 
DV2- Venous 
blood samples 
were taken in 
the morning 
between 07:45 
and 0900 h 
after a 10-h 
fast. All 
samples 
consisted of 
whole blood 
drained into 6-
mL serum 
separation 
tubes, plasma 
separation 
A power 
analysis was 
performed. 
Linear mixed 
effect models 
with random 
intercept and 
unstructured 
covariance’s 
for repeated 
measures 
within a 
patient. 
At 12 weeks: 
 
DV1- BMI 
Mean 27.8, 
mean change -
2.5, p< 0.001 
 
DV2- A1C 
Mean 49.20, 
mean change  
-12.37, p< 
0.001 
 
DV3- Health 
related quality 
of life 
(physical 
functioning) 
Mean 86.5, 
mean change 
10.8, p< 0.001 
Level IV 
 
Strengths: 
A significant 
body weight 
reduction was 
seen after 
introduction of 
the new diet 
(Okinawan). 
 
Weaknesses: 
A significant 
increased in HDL 
cholesterol was 
observed. 
A limitation of 
the study was that 
no control group 
was included. 
Conclusion: 
The Okinawan 
diet seems to 
contribute to the 
improvement on 
A1C levels, blood 
pressure, weight 
and physical 
functioning but 
further research 
needs to be 
implemented. 
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Skane University 
Hospital. 
 
Bias: 
Selection bias 
(Excluded patients 
from different 
ethnicities). 
psychiatric 
diseases. 
Pts with severe 
liver 
insufficiency, 
INR > 1.1, or 
severe renal 
insufficiency. 
GFR < 30. 
 
Attrition: 
2 (6.7 %). 
tubes, and 
Microtainer 
tubes with 
EDTA (BD 
Biosciences, 
Franklin Lakes, 
NJ). Blood 
chemistries 
were analyzed 
continually 
during the 
study.  
 
DV3- RAND 
36 Item Health 
Survey. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feasibility: 
Recommended to 
use in practice. 
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Estruch et al. 
(2013) Primary 
prevention of 
cardiovascular 
disease with a 
Mediterranean diet  
 
Country: 
Spain 
 
Funding: 
Supported by the 
official funding 
agency for 
biomedical 
research of the 
Spanish 
government, 
Instituto de Salud 
Carlos III. 
 
Bias: 
Dr. Estruch reports 
serving on the 
board of and 
receiving lecture 
fees from the 
Research 
Foundation on 
Wine and 
Nutrition, serving 
on the boards of 
the Beer and 
Health Foundation 
and the European 
Pender’s 
Health 
Promotion 
Model 
Design: 
Parallel-group, 
multicenter, 
randomized trial. 
 
Purpose: 
Observational cohort 
studies and a 
secondary prevention 
trial have shown an 
inverse association 
between adherence to 
the Mediterranean diet 
and cardiovascular 
risk.  
n-7, 447 
 
IG1- 2543 
IG2- 2454 
CG- 2450 
 
Demographics: 
Male and 
females, age 
range- 55-80-
year-old 
 
Setting: 
Universidad 
Medica de 
Navarra, Spain. 
 
Inclusion: 
Males, females, 
with no 
cardiovascular 
disease at 
enrollment, who 
had either type 2 
diabetes or at 
least three of the 
following major 
risk factors: 
smoking, 
hypertension, 
elevated low-
density 
lipoprotein 
cholesterol levels, 
low high-density 
IV- 
Mediterranea
n diet 
 
DV1- with 
EVOO 
 
DV2- with 
nuts 
 
Time frame 
of the 
intervention: 
 
4.8 years. 
 
 
IV- 
Mediterranea
n diet. 
 
DV1- 14-Item 
dietary 
screener to 
measure 
adherence to 
the 
Mediterranean 
diet. 
 
DV2- 14-Item 
dietary 
screener to 
measure 
adherence to 
the 
Mediterranean 
diet. 
With the use 
of O’Brien 
Fleming 
stopping 
boundaries, 
the P values 
for stopping 
the trial at 
each yearly 
interim 
analysis. All 
primary 
analyses were 
performed on 
an intention-
to-treat basis 
by two 
independent 
analysts.  
Cox 
regression 
models were 
used to adjust 
for sex, age, 
and baseline 
risk factors. 
At End Point: 
 
DV1- Primary 
end point: 8.1 
(6.6-9.9) 
p=0.009 
 
DV2-Primary 
end point: 8.0 
(6.4-9.9) 
p=0.02 
Level I 
 
Strengths: 
 
In this trial an 
energy 
unrestricted 
Mediterranean 
diet supplemented 
with either extra-
virgin olive oil or 
nuts resulted in an 
absolute risk 
reduction of 
approximately 3 
major 
cardiovascular 
events per 1000 
person-years, for 
a relative risk 
reduction of 
approximately 
30% among high 
risk persons who 
were initially free 
of cardiovascular 
disease. 
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Foundation for 
Alcohol Research. 
lipoprotein 
cholesterol levels, 
overweight or 
obesity, or a 
family history of 
premature 
coronary heart 
disease.  
 
Exclusion: 
Not specified. 
 
Attrition: 
523 (7.0%) 
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Johansen et al. 
(2017) 
Effect of an 
intensive lifestyle 
intervention on 
glycemic control in 
patients with type 
2 diabetes. 
 
Country: 
Denmark 
 
Funding: 
TrygFonden. The 
Centre for Physical 
Activity Research. 
Centre for 
Inflammation and 
Metabolism, 
Danish Council for 
Strategic Research, 
Danish Diabetes 
Academy 
(supported by the 
Novo Nordisk 
Foundation) 
 
Bias: 
Novo Nordisk 
Foundation 
(pharmaceutical 
company) even 
though funders had 
no role in the 
Pender’s 
Health 
Promotion 
Model 
Design: 
Randomized Clinical 
Trial 
 
Purpose: 
To evaluate the 
effectiveness of 
lifestyle intervention 
on glycemic control in 
patients with T2D. 
n- 93 
IG-62 
CG-31 
Demographics: 
Male and females 
(adults- age was 
not specified). 
Educational level 
(was not 
specified). 
 
Setting: 
Rigshospitalet, 
Copenhagen, 
Denmark. 
 
Inclusion: 
Adults with T2D 
diagnosed < 10 
years, BMI of 25-
40, taking 2 or 
fewer glucose-
lowering 
medications. 
 
Exclusion: 
A1C > 9.0, 
insulin 
dependence, 
presence of one 
or more of the 
following 
complications: 
diabetic 
retinopathy, 
IV1- Aerobic 
training 
sessions. 
IV2- 
Resistance 
training 
IV3- diet 
 
DV1- A1C 
DV2- glucose 
lowering 
medication 
 
Time frame: 
12 months 
 
Diet 
(consistent on 
45-6-% 
carbohydrates, 
15% to 20% 
protein, and 
20% to 35% fat 
with < 7% 
saturated fat). 
implemented in 
the Region of 
Zealand and 
Denmark 
 
DV1-
Measurements 
were 
performed in 1 
laboratory and 
biochemical 
analysis were 
completed at 
the central 
laboratory 
using standard 
procedures. 
 
 
DV2-the study 
endocrinologist 
titrated the 
patient’s 
glucose-
lowering 
medication to 
Repeated-
measures 
analysis of 
covariance 
applied in 
mixed linear 
models. 
DV1-A1C- 
Change (95% 
CL) -0.31(-
0.45 to -0.16) 
p value .15 
(not 
significant) 
 
DV2- glucose 
lowering 
medication- 
Change (95% 
Cl) -2.0 (-3.0 
to -1.0) 
p<0.001 
Level II 
 
Strengths: 
Lifestyle 
intervention led to 
a substantial and 
parallel reduction 
in glucose-
lowering 
medication. 
 
Weaknesses: 
Only participants 
with DM2 
diagnosed for < 
10 years were 
included. Also the 
self-reported 
dietary intake in 
this study is 
subject to biases 
and limitations.  
Conclusions: 
The A1C changes 
were no 
significant as 
expected (p 
value= 0.15). 
 
Feasibility: 
Recommended to 
use in practice. 
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design and conduct 
of the study. 
macro 
albuminuria, 
nephropathy.  
 
Attrition: 
5 (5.10%) 
obtain 
prescribed 
treatment 
targets. 
Medical 
standardization 
was performed 
to assess the 
effect of the 
lifestyle 
intervention 
without 
amplifying the 
result due to 
poorly 
regulated A1C 
levels at 
baseline. Data 
collected at 
Rigshospitalet, 
Copenhagen, 
Denmark. 
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Jung et al. (2014)  
Beneficial effects 
of Korean 
traditional diets on 
hypertension and 
type 2 diabetic 
patients. 
 
Country: 
Republic of Korea 
 
Funding: 
Grants provided by 
the Ministry for 
Food, Agriculture, 
Forestry and 
Fisheries, Korean 
Food Foundation. 
 
Bias: 
No bias reported. 
 
 
Physiologic 
Model 
Design: RCT 
 
Purpose: 
To evaluate the 
efficacy of the KTD in 
controlling fasting 
plasma glucose, BP 
and CVD risk factors 
in hypertensive and 
T2D patients. 
 
n-41 
IG-21 
CG-20 
Demographics: 
Age: > 18 yrs.  
m/f- 54/46% 
 
Setting: 
Chonbuk 
National 
University 
Hospital 
 
Inclusion: 
Diagnosed with 
HTN and T2D. 
Taking oral meds 
for HTN, plasma 
glucose and 
lipids. 
 
Exclusion: 
DBP > 116 
mmHg, or 
SBP>200. Hx of 
CV events; type 1 
diabetes; 
uncontrolled 
T2D, Hx CA; 
retinopathy or 
neuroretinopathy; 
digestive or CNS 
disorders; renal 
and liver 
function; 
IV- KTD 
 
DV1-Body 
weight 
DV2- BMI 
DV3- body 
fat mass 
DV4- body 
fat (%) 
DV5- waist 
hip-ratio 
DV6- A1C 
DV7 – HR 
 
Time frame: 
3 X day for 
12 weeks 
DV1- 
measured using 
a digital scale 
while the 
subjects were 
wearing a light 
hospital gown.  
 
DV2- was 
calculated by 
weight 
(kg)/height 
(m)2 
 
DV3-
determined 
using a 
bioelectric 
impedance 
analyzer. 
 
DV4-
determined 
using a 
bioelectric 
impedance 
analyzer. 
DV5- waist 
circumference 
was measured 
twice to the 
nearest 0.1 cm 
with a 
measuring tape 
at the midpoint 
All stats were 
performed 
according to 
the pre-
established 
protocol using 
SPSS version 
18.0 
Repeated 
measures 
mixed model 
analysis of 
variance was 
performed to 
determine the 
effects 
associated 
with time. 
At 12 weeks: 
 
DV1 -2.3+- 
0.7 p<0.002 
 
DV2 -0.83+-
0.2 p< 0.002 
DV3 -2.1+-0.5 
p<0.001 
DV4 -2.2+-0.6 
p< 0.001 
DV5 -0.03+-
0.01 p 0.202 
(not 
significant) 
DV6 –0.72+-
0.1 p<0.003 
DV7 -7.1+-1.8 
p<0.002 
Level II 
 
Strengths: 
The study proved 
the efficacy of the 
KTD diet for 
hypertensive and 
diabetic patients, 
resulting in 
favorable changes 
in glycemic 
control, body 
composition, HR 
and CVD risk 
factors. 
 
Weaknesses: 
Waist hip ratio 
was not 
significant (p 
0.202), the control 
group was not 
provided a strict 
“controlled diet” 
per se nor 
monitored closely 
for their dietary 
intake as was 
done for the KTD 
group. 
 
Conclusion: 
The Korean diet 
improved glucose 
levels, weight, 
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dysproteinemia; 
nephritic 
syndrome; renal 
diseases; 
coagulopathy; 
HIV; Psych meds 
in last 2 months; 
gastric bypass 
surgeries; 
participants of 
clinical trials (last 
2 months); ETOH 
hx; pregnant 
and/or 
breastfeeding. 
 
Attrition: 
7 (14.6%) 
 
 
 
 
between the 
lower border of 
the ribs and the 
upper border of 
pelvis. Hip 
circumference 
was measured 
at the largest 
extension of 
the buttocks.  
DV6- Blood 
samples were 
collected after 
12 h fasting 
and were 
stored at -80C 
until further 
analysis. 
HbA1c by the 
Hitachi-7600 
analyzer. 
DV7-vital 
signs were 
obtained using 
standard 
protocols. 
 
 
 
 
 
 
 
 
 
BMI, blood 
pressure, heart 
rate, it could be 
an appropriate 
intervention for 
diabetic patients 
type 2. 
 
Feasibility: 
Recommended to 
use in practice. 
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Kollannoor-
Samuel et al. 
(2016) 
Nutrition facts 
panel use is 
associated with 
higher diet quality 
and lower glycated 
hemoglobin 
concentrations in 
US adults with 
undiagnosed pre-
diabetes. 
 
Country: 
United States 
 
Funding: 
No funding 
received 
 
Bias: 
Selection bias 
(Excluded pts from 
other ethnic 
groups, they were 
mostly Caucasian 
with higher 
socioeconomic 
status. 
Health 
Belief 
Model 
Design: 
Weighted linear 
regression with the use 
of cross-sectional data 
(study). 
 
Purpose: 
To compare the 
associations between 
components of food 
label use on the overall 
diet quality of 
individuals with pre-
diabetes. 
n- 2599 
 
Demographics: 
Males and 
females 
Middle-aged, 
non-Hispanic 
whites, some 
college education, 
above-poverty-
threshold family, 
born in the 
United States. 
 
Setting: 
Department of 
Chronic Disease 
Epidemiology, 
Yale School of 
Public Health, 
New Haven, CT. 
 
Inclusion: 
Diagnosed with 
pre-diabetes,  
Adults > 18 years 
of age, A1C > 5.7 
and < 6.5, fasting 
plasma glucose > 
100 and < 126, or 
2-hour oral 
glucose tolerance 
test blood glucose 
> 140 and < 200. 
Exclusion: 
IV- Food 
labels 
 
DV1- Diet 
quality 
 
DV2- A1C 
 
Time frame 
of the 
intervention: 
5 years 
DV1- assessed 
with the use of 
the Healthy 
Eating Index 
(HEI)-2010, 
diet-scoring 
metric. 
 
DV2- Blood 
samples were 
collected at 
NHANES 
Mobile 
Examination 
Centers. A1C 
concentrations 
were obtained 
with the use of 
the Tosoh 
A1c2.2 
Descriptive 
statistical 
analyses were 
conducted in 
SAS 9.4 
software.  
 
DV1 p< 0.001 
 
DV2 (for 
people that 
read both 
labels-health 
claims and 
nutrition facts 
panel) A1C 
0.10 (0.03, 
0.17) p 0.009 
Level V 
 
Strengths: 
The study 
concluded that 
individuals who 
do not use the 
nutrition facts 
panel have poorer 
diet quality. 
The study was not 
affected by 
selection bias 
because the 
sample was 
selected 
independently of 
subject food label 
use, diet quality, 
or A1C 
concentration. 
 
Weaknesses: 
First study to 
examine the 
association 
between nutrition 
fact panel and 
health claims 
labels, together 
and separately. 
Conclusion: 
The use of both 
labels had a 
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Pregnant women, 
undiagnosed pre-
diabetes, patients 
that self-reported 
diabetes/pre-
diabetes, 
participants 
without 2 reliable 
24-hour recalls, 
participants 
without responses 
to health-claim 
questions. 
 
Attrition: 
 55 (2.07%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
significant level 
(p 0.009) 
 
Feasibility: 
Recommended to 
use in practice. 
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Martinez-Gonzalez 
et al. (2012) 
A 14-Item 
Mediterranean 
Diet Assessment 
Tool and Obesity 
Indexes among 
High-Risk 
Subjects: The 
PREDIMED Trial 
 
Country: 
Spain 
 
Funding: 
Biomedical 
Research of the 
Spanish 
Government, 
Patrimonio 
Comunal Olivarero 
and Ojiblanca from 
Spain (extra-virgin 
olive oil), the 
California Walnut 
Commission from 
Sacramento 
California 
(walnuts), Borges 
S. A. (almonds), 
and La Morella 
Nuts (hazelnurs) 
Spain. 
 
Bias: 
Health 
Belief 
Model 
Design: Cross 
sectional assessment 
of all participants in 
the “Prevencion con 
dieta Mediterranea” 
PREDIMED trial 
 
Purpose: 
Intervention using a 
dietary assessment tool 
Sample:  
7447 participants 
 
Setting: 
Spanish Primary 
Care Centers 
 
Inclusion: 
Women (60-80 
years of age) 
Men (55-80 years 
of age) without 
prior 
cardiovascular 
disease but at 
high 
cardiovascular 
risk because they 
have Type II 
diabetes or at 
least three major 
cardiovascular 
factors 
 
Exclusion: 
Children, adults 
older than 80 
years old 
 
 
IV1- Diet 
adherence 
 
DV1-BMI 
 
DV2-Diabetes 
Type II 
 
DV3- 
Mediterranea
n Assessment 
Tool 
 
 
DV1- BMI was 
measured by 
trained nurses 
who measured 
weight, height 
and waist 
circumference. 
 
DV2- Type II 
DM was 
measured on 
their primary 
care clinic. 
 
DV3- 
Mediterranean 
Assessment 
Tool- 
Dietitians 
assessed in a 
face-to-face 
interview with 
each 
participant. 
All analysis 
were 
conducted 
with one-way 
ANOVA and 
chi-square 
tests. 
Results: 
 
DV1-BMI p < 
0.001 
 
DV2- Type II 
DM p < 0.010 
 
DV3- For a 
two-point 
increment in 
the 14-item 
score, the 
multivariable-
adjusted 
differences in 
WHtR were 
20.0066 (95% 
confidence 
interval, – 
0.0088 to 
20.0049) for 
women and –
0.0059 (–
0.0079 to –
0.0038) for 
men. The 
multivariable-
adjusted odds 
ratio for a 
WHtR.0.6 in 
participants 
scoring $10 
points versus 
#7 points was 
Level III 
 
Strengths: 
Results suggest 
that closer 
adherence to a 
Mediterranean 
diet is associated 
with a lower 
prevalence of 
obesity, 
specifically 
abdominal 
obesity. 
 
Weaknesses: 
The main 
limitation relates 
to the cross-
sectional nature of 
our analysis and 
the potentiality 
for reverse 
causality bias. 
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Potential bias 
would be towards 
finding a higher 
adherence to a 
healthier 
Mediterranean diet 
among overweight 
or obese subjects. 
 
  
0.68 (0.57 to 
0.80) for 
women and 
0.66 (0.54 to 
0.80) for men. 
High 
consumption 
of nuts and 
low 
consumption 
of 
sweetened/carb
onated 
beverages 
presented the 
strongest 
inverse 
associations 
with 
abdominal 
obesity.  
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Rock et al. (2014) 
Weight loss, 
glycemic control, 
and cardiovascular 
disease risk factors 
in response to 
differential diet 
composition in a 
weight loss 
program in type 2 
diabetes: A 
randomized 
controlled diet. 
 
Country: 
United States of 
America 
 
Funding: 
Was provided 
through a clinical 
trial contract to the 
coordinating center 
(School of 
Medicine, UCSD). 
Jenny Craig 
provided program 
activities and 
materials including 
prepackaged foods. 
 
Bias: 
This study was 
supported by Jenny 
Craig by 
Physiologic 
Model 
Design:  
Randomized 
Controlled Trial 
 
Purpose: 
To evaluate the 
effectiveness of a 
weight loss program in 
weight loss, glycemic 
control and CVD risks 
in T2D patients. 
n- 225 
IG1- 73 
IG2- 76 
CG- 76 
 
Demographics: 
Males and 
females (adults) 
Aged > 18 years 
 
Settings: 
University of 
California (San 
Diego) and 
University of 
Minnesota 
(Minneapolis) 
 
Inclusion: 
History of T2D, 
aged > 18 years, 
BMI 25-45, not 
pregnant or 
breastfeeding or 
planning to 
become pregnant 
in the next year, 
willing to 
participate in any 
of the study diet 
arms over a 1-
year period, no 
eating disorders, 
food allergies or 
food intolerances, 
IV1- high 
carbohydrate 
low fat diet 
plan 
IV2- lower 
carbohydrate, 
higher fat diet 
plan 
 
DV1- weight 
loss 
DV2- 
glycemic 
control 
markers 
DV3- 
triglyceride 
levels 
DV4- A1C 
 
Time frame 
of the 
intervention: 
One year. 
DV1 Weight 
was measured 
at the clinic (it 
does not 
specify how it 
was measured) 
 
DV2 Fasting 
>6h blood 
samples were 
collected at 
each clinic visit 
and were 
measured with 
the Kodak 
Ektachem 
Analyzer 
system. 
 
DV3 Fasting 
>6h blood 
samples were 
collected at 
each clinic visit 
and were 
measured with 
the Kodak 
Ektachem 
Analyzer 
system. 
 
DV4 A1C was 
measured in 
washed 
erythrocytes 
All analysis 
were 
conducted 
with SAS 9.3 
statistical 
software. 
At 12 months: 
 
DV1 weight- 
101.9 (17.4) p 
0.005 
 
DV2 glycemic 
control 
markers- 
(glucose 141 
(133-149) 
mg/dL, p= 
0.023 (not 
significant) 
 
DV3 
triglycerides 
148 (134-163), 
p < 0.001 
 
DV4 A1C 
6.9% (6.6-
7.1%) p= 
0.001 
Level II 
 
Strengths: 
Glycemic control 
and weight loss 
improved in DM2 
patients. 
At 1 year, 
participants in the 
weight loss 
program 
intervention lost 
8.2% of initial 
weight compared 
with a 2.5% 
weight loss in the 
control group. 
Weaknesses: 
Lack of 
information about 
adherence to the 
prescribed diets.  
The target was a 
free-living 
population, so 
variability in 
adherence is 
likely. Self-
reported dietary 
data have well-
recognized 
limitations in 
accuracy. 
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agreement scientist 
at UCSD and the 
University of 
Minnesota have 
independence 
regarding data 
management, 
analysis and 
publication. 
no history of 
bariatric surgery, 
willing to 
perform a step 
test for assessing 
cardiopulmonary 
fitness. 
 
Exclusion: 
Current 
involvement in 
another diet 
intervention study 
or weight loss 
program, weight 
loss > 10 lb in the 
past 3 months, 
having a 
psychiatric 
disorder, A1C > 
11%, fasting 
triglyceride > 600 
mg/dL and serum 
creatinine level > 
1.4 (women) or 
1.5 (men). 
 
Attrition: 
2 (0.88%). 
 
 
 
 
 
 
with ion 
exchange high-
performance 
liquid 
chromatograph
y. 
Conclusion:  
Following a 
regimen with a 
diet plan low in 
calories is proven 
to improve A1C 
levels, weight loss 
and triglyceride 
levels. 
 
Feasibility: 
Recommended to 
use in practice. 
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Shiau et al. (2018) 
Effects on diabetes 
medications, 
weight and 
glycated 
hemoglobin among 
adult patients with 
obesity and type 2 
diabetes: 6 month 
observations from 
a full meal 
replacement, low-
calorie diet weight 
management 
program. 
 
Country: 
Canada 
 
Funding: 
Ottawa Hospital 
Weight 
Management 
Clinic 
 
Bias: 
Excluded patients 
that were not 
registered on the 
registry. 
No other bias 
found. 
Pender’s 
Health 
Promotion 
Model 
Design: 
Retrospective Cohort 
Study 
 
Purpose: 
To evaluate the 
effectiveness of a meal 
replacement 
supervised weight 
management program 
in patients with T2D. 
N-5  
n-317 
IG1- 235 
IG2- 82 
 
Demographics: 
Pt who where 
registered at the 
local registry. 
Males and 
females 
Setting: 
Ottawa Hospital 
Weight 
Management 
Clinic in Ontario, 
Canada 
 
Inclusion: 
Pt who had T2D, 
taking 
medications, A1C 
> 6.5 or higher on 
2 separate 
occasions. 
 
Exclusion: 
Non compliance 
in the behavioral 
program (taking < 
50% of the meal 
replacements, 
attending fewer 
than 6 sessions in 
the program. 
IV- Meal 
replacement 
 
DV1- weight 
DV2- A1C 
DV3- 
medication 
intake. 
 
Time frame 
of the 
intervention-  
6 months 
DV1 (not 
specified) 
 
DV2 (not 
specified) 
 
DV3 primary 
physician had 
the goal to 
reduce 
medication 
intake, 
specially 
(insulin, 
sulfonureas, 
thiazolidinedoi
nes and/or 
meglitinides), 
which are 
medications 
that are 
attributed to 
increase 
weight. The 
study does not 
mention the 
reduction rate 
of the 
medications.  
ANOVA 
Chi-square  
ANOVA 
using a mixed 
between-
within subject 
analysis 
Linear 
regression. 
 
At 6 months: 
 
DV1 weight 
For group who 
is taking 
weight gain 
medications: 
16.7% (6.7), 
p<0.0001 
Weight for 
group who is 
taking neutral 
medications: 
16.8% (6.9) 
p<0.0001 
 
DV2 A1C 
For group who 
is taking 
weight gain 
medications: 
6.7% (1.6) 
p<0.0001 
For group who 
is taking 
neutral 
medications: 
5.8% (1.3) 
p<0.0001 
DV3 
medication 
intake 
At 6 months: 
Weight: 16% 
(6.7) p<0.0001 
Level: IV 
 
Strengths: 
Full meal 
replacement-low 
calorie diet 
behavior 
programs can be 
regulated for 
strategic breaking 
of the cycle that 
patients are 
caught in with 
respect to their 
weight, allowing 
patients to 
achieve lower 
weights and 
subsequently 
“reset” 
themselves. 
 
Weaknesses: 
This is a 
retrospective 
cohort and the 
rationales for 
choices of initial 
diabetes 
medications 
cannot be 
elucidated. The 
analysis was 
restricted to 
weight and 
DIET MODIFICATION IN TYPE II DIABETIC PATIENTS  
Key: A1C- glycated hemoglobin; BMI- body mass index; BP- blood pressure; CA- cancer; CNS- central nervous system; CV- 
cardiovascular; CG- control group; DV-dependent variable; GFR- glomerular filtration rate; HTN- hypertension; INR- international 
normalized ratio; IV- independent variable; IG- intervention group; N-number of studies; n- number of participants; RCA – 
Randomized Control Trial; T2D- type two diabetes. 
 
57 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major 
Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Attrition: 
0% 
 
 
A1C: 6.6% 
(1.6) p<0.0001 
glycemic control 
in patients with 
obesity and 
diabetes taking 
medications at 6 
months. 
 
Conclusion: 
Weight gaining 
medications are a 
big barrier to loss 
weight and 
improve mobility. 
Meal replacement 
shakes could 
assist patients to 
lose weight, and 
improve A1C 
levels. 
 
Feasibility: 
Recommended to 
use in practice. 
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Sylvetsky et al. 
(2017). 
A high-
carbohydrate, 
high-fiber, low-fat 
diet results in 
weight loss among 
adults at high risk 
of type 2 diabetes. 
 
Country: 
United States 
 
Funding: 
Provided by the 
National Institute 
of Diabetes and 
Digestive and 
Kidney Diseases. 
  
Bias: 
Not reported. 
 
 
Physiologic 
Model 
Design: 
Multicenter, 
randomized controlled 
clinical trial. 
 
Purpose: 
To evaluate the 
association between 
diet and weight at 
baseline and to 
identify specific 
dietary factors that 
predicted weight loss 
among adults with 
high risk of diabetes 
type 2. 
 
 
n- 2,924 
IG1- 967 
IG2- 979 
CG- 978 
 
Demographics: 
Male and females 
> 25 years of age. 
 
Setting: 
Information was 
collected through 
the years in 
multiple settings, 
it is not specified 
where the 
collection centers 
were located. 
 
Inclusion: 
Participants 
needed to be > 25 
years of age, had 
a BMI > 24 (>22 
for Asian 
Americans), and 
had elevated 
fasting plasma 
glucose 
concentrations 
(95-125 mg/dL or 
5.3-6.9 mmol/L) 
and impaired 
glucose tolerance 
(140-199 mg/dL 
IV1- Lifestyle 
(high-
carbohydrate, 
high-fiber, 
low-fat diet) 
IV2 – 
Metformin 
 
DV1- Weight 
loss 
 
Time frame 
of the 
intervention: 
3 years. 
DV1- Does not 
mention how 
they measured 
the 
participant’s 
weight. 
Linear 
regression 
SAS version 
9.3 was used 
for all 
analyses 
(SAS 
Institute). 
At 12 months: 
 
DV1- Weight 
loss using low 
fat-
carbohydrate 
intake diet 
(-1.14+-0.18 
kg body 
weight/100 
kcal 
carbohydrate, 
p< 0.0001) 
specifically, 
dietary fiber (-
1.26 +- 0.28 
kg/5g fiber, 
p<0.0001). 
 
 
Level II 
 
Strengths: 
Weight loss after 
1 year was 
associated with 
increases in 
carbohydrate 
intake, 
specifically 
dietary fiber, and 
decreases in total 
fat and saturated 
fat intake. 
Weaknesses: 
There is no 
measurement on 
participant’s 
weight (it is not 
mention in the 
study) 
 
Conclusion: 
Given the 
widespread public 
perception that 
carbohydrates are 
detrimental in 
increasing 
diabetes risk and 
the increasing 
prominence of 
low-carbohydrate 
diets for weight 
loss, the current 
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or 7.8-11.0 
mmll/L) during 
an oral-glucose-
tolerance test. 
 
Exclusion: 
Participants < 25 
years of age, BMI 
< 24, no elevated 
fasting plasma 
glucose 
concentrations 
(<95) and 
impaired glucose 
tolerance (<140) 
during an oral-
glucose-tolerance 
test. 
 
Attrition: 
310 (9.6%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
findings are 
critical to the 
development of 
evidence-based 
recommendations 
for optimal 
dietary 
approaches to 
prevent diabetes. 
 
Feasibility: 
Recommended to 
use in practice. 
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Wolever et al. 
(2017) 
Effects of 
changing the 
amount and source 
of dietary 
carbohydrates on 
symptoms and 
dietary satisfaction 
over a 1-year 
period in subjects 
with type 2 
diabetes: Canadian 
trial of 
carbohydrates in 
diabetes. 
 
Country: 
Canada 
 
Funding: 
Author obtained 
funding for the 
study. 
 
Bias: 
Author is partial 
owner of Glycemic 
Index 
Laboratories. 
Received 
consulting fees 
from McCain 
Foods, Bunge, and 
Temasek 
Health 
Belief 
Model 
Design: 
Randomized Control 
Trial 
 
Purpose: 
To evaluate if the 
long-term effects of 
changing the amount 
of carbohydrates on 
quality of life, 
symptoms and dietary 
satisfaction in T2D 
patients.  
n-130 
IG1- 41 
IG2- 45 
IG3- 44 
 
Demographics: 
Males and 
females 35 to 75 
years of age 
 
Setting: 
Department of 
Nutritional 
Services, Ontario 
Canada 
 
Inclusion: 
Men and no 
pregnant women 
with T2D (fasting 
plasma glucose 
>7.0 mmol/L or 
2-hour plasma 
glucose after 75G 
oral glucose 
tolerance test > 
11.1 mmol/L, 
whose diabetes 
was managed by 
diet alone. 
35-75 years of 
age, had A1C < 
13.0 and BMI 24 
to 40, otherwise 
healthy.  
IV1- High-
Glycemic 
Index Diet 
IV2- Low 
glycemic 
index diet 
IV3- Low 
carbohydrate 
diet 
 
DV1- quality 
of life 
DV2- GI 
symptoms 
DV3- Dietary 
satisfaction 
 
Time frame 
of the 
intervention: 
12 months 
DV1- Quality 
of life 
The Quality of 
Life 
questionnaire 
was adapted 
from validated 
questionnaires 
and was filled 
out at baseline 
and at 12 
months. The 5 
domains of the 
questionnaire-
general health 
(3 items), 
diabetes 
management 
self-efficacy (4 
items), energy 
(5 items), 
emotional 
well-being (4 
items) and 
physical 
functioning (13 
items)- were 
scored as the 
weighted 
average of the 
scores on each 
item, with each 
item given 
equal weight. 
 
Dietary 
intakes and 
quality of life 
scores were 
assessed 
using analysis 
of variance 
(ANOVA). 
The 
Spearman 
correlation 
coefficient 
was used to 
assess the 
correlation 
among 
variables. 
DV1- Quality 
of life 
(no differences 
in QOL among 
the diet groups 
at baseline, 
and end of 
study) 
DV2- GI 
symptoms 
Flatulence 
associated with 
fiber intake 
(7.8+-1.4, 
p=0.019) 
DV3- Dietary 
satisfaction 
Low 
carbohydrate 
diet 
(p=0.0065) 
and greater 
enjoyment of 
eating 
(p=0.0003). 
Level II 
 
Strengths: 
The study shows 
that diets 
containing 40% of 
energy from 
carbohydrate may 
be more satisfying 
to adults with 
type 2 diabetes 
than those 
containing 50% 
carbohydrate. 
Weaknesses: 
Their findings of 
dietary 
satisfaction need 
to be interpreted 
with caution 
because the 
intervention they 
used is different 
from usual dietary 
advice that 
requires clients to 
provide their own 
foods. Therefore, 
the findings may 
not necessarily 
apply to standard 
medical nutrition 
therapy. 
A1C levels 
increased over the 
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Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major 
Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Polytechnic; other 
authors did not 
report any relevant 
conflicts of 
interest. 
 
Exclusion: 
Pregnant women, 
people older than 
75 years of age, 
A1C > 13 %, 
BMI > 40. 
 
Attrition: 
32 (20%) 
 
DV2- GI 
symptoms 
The symptom 
questionnaire 
is the same as 
that used in our 
previous trial 
of acarbose in 
the treatment 
of diabetes. 
 
 
DV3- Dietary 
satisfaction 
The dietary 
satisfaction 
questionnaire 
was adapted 
from that used 
in the Diabetes 
Control and 
Complications 
Trial. 
1-year period of 
the study, and 
there was no 
significant 
difference in A1C 
level change in 
the three diets 
(High-GI diet, 
Low GI diet and 
Low carbohydrate 
diet). 
Conclusion: 
According to the 
study hemoglobin 
A1C levels 
decreased less in 
those patients that 
gain less weight. 
Some variation is 
shown regarding 
the three diets 
presented on the 
study. 
 
Feasibility: 
Needs further 
evaluation. 
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Appendix F  
 
Table 1 
Synthesis Table 
Study 
Details 
          
Author Andrews Coppell Darwiche Johansen Jung Kollannoor Rock Shiau Sylvetsky Wolever 
Year 2011 2017 2016 2017 2014 2016 2014 2018 2017 2017 
Design RC 
multicenter 
Mixed 
methods 
non 
randomized 
Study 
Trial 
clinical 
prospective 
Study 
RCT RCT Weighted 
linear 
regression 
RCT Retrospective 
Cohort 
Study 
Multicenter 
RCT 
RCT 
Level of 
Evidence 
II III IV II II V II IV II II 
Number of 
subjects 
593 133 28 93 41 2566 225 317 2924 130 
Independent 
Variables 
          
Diet X X X X X  X X X X 
Physical 
activity 
X   X       
Food label      X     
Medication         X  
Dependent 
Variables 
          
A1C levels ↑ ↓ ↑ ↓ ↑ ↑ ↑ ↑  ± 
Weight ↑ ↑   ↑  ↑ ↑ ↑  
BMI   ↓  ↑      
Findings           
Risk or 
Harm if 
Implemented 
None None None None None None None None None None 
 
↑ Independent variable showed a statistically significant positive association with dependent variable  
↓ Independent variable showed a statistically significant negative association with dependent variable 
±- Intervention showed no statistical difference 
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Table 2 
Synthesis Table 
Study 
Details 
   
Author Cubillos Estruch Martinez-Gonzalez 
Year 2017 2013 2012 
Design Clinical pilot Parallel group-multicenter randomized trial Cross sectional assessment 
Level of 
Evidence 
III I III 
Number of 
subjects 
19 7447 7447 
Independent 
Variables 
   
Diet X X X 
Physical 
activity 
   
Food label    
Medication    
Dependent 
Variables 
   
A1C levels ↓ ± ↑ 
Weight ↓ ↑  
BMI  ↑ ↑ 
Findings    
Risk or 
Harm if 
Implemented 
None None None 
 
↑ Independent variable showed a statistically significant positive association with dependent variable  
↓ Independent variable showed a statistically significant negative association with dependent variable 
±- Intervention showed no statistical difference 
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Appendix G 
 
Figure 1.1 Diagram of Rosswurm & Larrabee Model 
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Appendix H 
 
Figure 1.1 Diagram of Pender’s Health Promotion Model 
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Appendix I 
Table 1 
Validated 14-Item Questionnaire of Mediterranean Diet Adherence  
Questions  Criteria for 1 point* 
 
1. Do you use olive oil as a main culinary fat? 
  
Yes 
2. How much olive oil do you consume in a given day (including oil used for frying, 
salads, out-of-house meals, etc.)? 
 More than 4 tbsp. 
3. How many vegetable servings do you consume per day? (200 g/7 oz. consider side 
dishes as half a serving) 
 More than 2 (more than 1 
portion raw or as a salad) 
4. How many fruits units (including natural fruit juices) do you consume per day?  More than 3 
5. How many servings of red meat, hamburger, or meat products (ham, sausage, tec.) do 
you consume per day? (1 serving 100-150 g/5 oz.). 
 Less than 1 
6. How many servings of butter, margarine or cream do you consume per day? (1 serving: 
12g/0.4 oz.) 
 Less than 1 
7. How many sweet or carbonated beverages do you drink per day?  Less than 1 
8. How much wine do you drink per week?  More than 7 glasses 
9. How many servings of legumes do you consume per week? (1 serving: 150g/5 oz.)  More than 3 
10. How many servings of fish or shellfish do you consume per week? (1 serving 100-150 g 
/ 5oz.of fish or 200 g/7 oz. of shellfish)  
 More than 3 
11. How many times per week do you consume commercial sweets or pastries (not 
homemade), such as cakes, cookies, biscuits or custard? 
 Less than 3 custard? 
12. How many servings of nuts (including peanuts) do you consume per week? (1 serving 
30 g/1 oz.) 
 More than 3 
13. Do you preferentially consume chicken, turkey, or rabbit meat instead of veal, pork, 
hamburger, or sausage? 
 Yes 
14. How many times per week do you consume vegetables, pasta, rice, or other dishes 
seasoned with sofrito (sauce made with tomato and onion, leek, or garlic and simmered 
with olive oil)? 
 More than 2 
*0 points if these criteria are not met. The score for adherence to the Mediterranean diet is based on the 14-Item PREDIMED dietary 
screener (0 indicates minimum adherence, 14 indicates maximum adherence).  
 
Permission to use the tool was obtained on 06/29/18 and provided by Dr. Miguel Angel Martinez-Gonzalez, MD, PhD, MPH from the 
University of Navarra Medical School in Navarra, Spain. 
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Appendix J 
 
Figure 1.1 IRB Approval Letter 
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Type of Review: Initial Study 
Title: DIET MODIFICATION IN TYPE II DIABETIC 
PATIENTS 
 
Investigator: Lynda Root 
IRB ID: STUDY00008541 
Category of review: (5) Data, documents, records, or specimens, (7)(a) 
Behavioral research 
Funding: None 
Grant Title: None 
Grant ID: None 
Documents Reviewed: • Informational_Flyer.pdf, Category: Recruitment 
Materials; 
• OPTUM_Approval.pdf, Category: Other (to reflect 
anything not captured above); 
• Consent Form, Category: Consent Form; 
• PRE_Mediterranean_Diet_Assessment_FINAL.pdf, 
Category: Measures (Survey questions/Interview 
questions /interview guides/focus group questions); 
• CITI TRAINING, Category: Other (to reflect 
anything not captured above); 
• GOALS.pdf, Category: Participant materials 
(specific directions for them); 
• Mediterranean_diet_general_guidelines.pdf, 
Category: Participant materials (specific directions for 
them); 
• Mediterranean Diet Type II Diabetes, Category: IRB 
Protocol; 
• Scoring for questionnaire, Category: Measures 
(Survey questions/Interview questions /interview 
guides/focus group questions); 
• HIPAA, Category: Other (to reflect anything not 
captured above); 
• Patient version-Questionnaire, Category: Measures 
(Survey questions/Interview questions /interview 
guides/focus group questions); 
• CITI TRAINING, Category: Other (to reflect 
anything not captured above); 
• IRB clarification letter, Category: Other (to reflect 
anything not captured above); 
•POST_Mediterranean_Diet_Assessment_FINAL.pdf, 
Category: Measures (Survey questions/Interview 
questions /interview guides/focus group questions); 
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The IRB approved the protocol from 7/30/2018 to 7/29/2019 inclusive. Three weeks before 
7/29/2019 you are to submit a completed Continuing Review application and required 
attachments to request continuing approval or closure.  
If continuing review approval is not granted before the expiration date of 7/29/2019 approval of 
this protocol expires on that date. When consent is appropriate, you must use final, watermarked 
versions available under the “Documents” tab in ERA-IRB. 
In conducting this protocol, you are required to follow the requirements listed in the 
INVESTIGATOR MANUAL (HRP-103). 
Sincerely, 
IRB Administrator 
cc: Ana Maria Burger 
Ana Maria Burger 
Johannah Uriri-Glover 
Lynda Root 
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Appendix K 
Figure 1.1 Demographics Questionnaire 
 
Demographics. 
Instructions: Please answer the following information about yourself (circle the correct answer) 
 
1. Gender:             Male            Female   
 
2. Age _______ (fill in years) 
 
3. Ethnicity:   White      Hispanic/Latino           Asian         Black/African American        Other__________    (write in) 
 
4. Marital status:         Single    Married     Widowed    Divorced   Other 
 
5. Primarily language:    English     Spanish      Other_________________(write in). 
 
6. Have you heard of a Mediterranean diet?  Yes        No        Not sure 
 
7. Have you tried a Mediterranean diet?         Yes       No 
 
8. Do you prepare your own food?                  Yes       No     Sometimes 
 
9. Who is the primary cook in your home (more than 50% of the time?)     Yourself   Spouse/Partner   Children    
Other_________(write in). 
 
10. Are you the primary grocery shopper in your home (more than 50% of the time?)     Yes    No 
 
11. Are you the primary meal planner (more than 50% of the time?)            Yes    No 
 
12. Which of the following categories best describe your employment status?    (Please check below) 
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Full time (40+ hours) _________          Part-time (30 or less) ________      Not Employed_______     
Retired_________ Disabled________ 
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Appendix L 
 
Figure 1.1 Dietary Goals 
 
DIETARY GOALS  
for session 1 and session 3 
 
Session 1 
 
 
 
Eat at least 3 portions of nuts every 
week 
 
 
 
 
 
Eat at least 1 portions of fish every 
week 
 
 
 
 
 
 
Eat at least 3 portions of natural 
dressing and/or mayonnaise every 
week, use healthy fats to fry, stew 
or bake 
 
 
 
 
 
 
 
 
No more than 2 portions of red meat 
per day 
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Reduce consummation of processed 
meat 
 
 
 
 
 
 
 
Choose margarine without trans fat 
 
 
 
 
 
 
Session 3 
 
 
 
 
Try to eat 4 or more 
portions of vegetables 
weekly 
 
 
 
 
 
 
 
Choose whole grains 
options, at least 2 portions 
a day 
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Choose healthy drinks 
 
 
 
 
 
 
 
 
Careful with chips and 
cookies. Choose the ones 
made with vegetable oil 
 
 
 
 
 
 
 
Eat legumes at least 3 
times a week 
 
 
 
 
 
 
 
Choose whole grains 
options for breakfast, at 
least 3 portions per week 
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Choose healthy options for 
snacks and desserts 
 
 
 
 
 
 
 
No more than 2 portions of 
cold or frozen dessert per 
week 
 
 
 
 
 
 
 
 
 
Try to eat 3 different fruits 
every day 
 
 
 
 
 
 
▪ Participants will be asked to select 2 achievable goals at each session. All potential goals 
for each session are listed. 
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Appendix M 
 
Figure 1.1 Informational Flyer 
 
 
  
The benefits of a Mediterranean Diet may 
include reduction of A1c and weight loss 
 
 
  
 
Patients 18 years or older with Type 2 Diabetes are invited to learn more 
about the proven health benefits of a Mediterranean diet!  
 
Sessions will be given by an RN/Doctor of Practice Student. 
Participation includes: 2 sessions on site (20 minutes each session) + 2 
coaching phone calls (5-15 minutes each) over an 8-week period 
(September-November 2018) 
Questionnaires and guidelines will be provided to each participant.  
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There is no cost to you and participation is voluntary. Each participant 
will receive a detailed information about the diet, a bottle of olive oil, a 
bag of nuts and a $10.00 Sprouts gift card upon completion. 
 
This is for a research study at Arizona State University 
 
For more information, contact:  
Ana Maria Burger RN ASU DNP Student @ (520) 304-3392 
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Appendix N 
 
Table 1 
Mediterranean Diet General Guidelines 
   
Recommended 
 
  
Olive oil  More than 4 tbsp./day 
Tree nuts and peanuts  More than 3 servings per 
week 
Fresh fruits  More than 3 servings per day 
Vegetables  More than 2 servings per day 
Fish (especially fatty fish), seafood  More than 3 servings per 
week 
Legumes  More than 3 servings per 
week 
Sofrito (mix of tomatoes, onion and garlic sauce)  More than 2 servings per 
week 
White meat  Instead of red meat 
Wine with meals (only for habitual drinkers)  7 glasses per week 
 
Discouraged 
 
  
Soda drinks  Less than 1 drink/day 
Commercial bakery goods, sweets, and pastries  Less than 3 servings/week 
Spread fats  Less than 1 serving/day 
Red and processed meats 
 
Each serving= 3 ounces 
 Less than 1 serving/day 
 
   
 
MORE RECOMMENDATIONS: 
 
● Cook at least twice a week with tomato, garlic and onion adding or not other aromatic 
herbs, and dress vegetables, pasta, rice and other dishes with tomato, garlic and onion 
adding or not aromatic herbs. This sauce is made by slowly simmering the minced 
ingredients with abundant olive oil.  
 
● Two main meals per day should be eaten (seated at a table, lasting more than 20 minutes). 
For usual drinkers, the dietitian’s advice was to use wine as the main source of alcohol 
(1-3 glasses of wine per day).  
 
● Walnuts, hazelnuts and almonds are highly recommended. As stronger evidence supports 
that alpha-linolenic acid-rich walnuts might offer special advantages in cardiovascular 
prevention.  
 
DIET MODIFICATION IN TYPE II DIABETIC PATIENTS  
 
 
79 
● Try to eliminate or limit the consumption of cream, butter, margarine, cold meat, pate, 
duck, carbonated and/or sugared beverages, pastries, industrial bakery products (such as 
cakes, donuts, or cookies), industrial desserts (puddings, custard), French fries or potato 
chips, and out-of-home pre-cooked cakes and sweets. 
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Appendix O 
 
Figure 1.1 Informed Consent 
 
Implementation of a Mediterranean Diet on Type 2 Diabetic Patients   
 
To Whom It May Concern: 
 
I am a doctoral student under the direction of Professor Lynda Root, DNP, RN in the Doctor of Nursing 
Practice Program at College of Nursing and Health Innovation at Arizona State University. I am 
conducting an evidence based project to introduce a Mediterranean diet with patients who have type 2 
diabetes. 
 
Your participation would involve - two (20 minutes) educational sessions at the clinic following your 
usual scheduled appointments; and two (5-15 minutes) phone conversations to review your progress (date 
and time to be determined with participants), completion of a pre and post-questionnaire and a 
demographics questionnaire (26 questions-five minutes to complete) on visit one, repeated on follow up 
visit two (14 questions to complete) during your usual scheduled appointment). Data will be taken from 
your medical record (weight and hemoglobin A1c) for study use to measure outcome of diet. The pre and 
post study questionnaire will be used to determine if the information has modified your diet.  This study is 
to be completed within two months and each session and questionnaire will be individually linked.  
Your participation in this study is voluntary. Participants need to be 18 years or older to be eligible to 
participate. There will be no penalty if you choose not to participate or to withdraw from the study at any 
time.  There is no additional cost to the participant, routinely collected lab results at the time of the visit 
will be used.  If you choose to participate, you have the right to skip any questions and to stop 
participation at any time. 
 
Benefits to participation include increased knowledge on the Mediterranean diet, potential weight loss and 
potential decrease on hemoglobin A1c level. Participants will receive a bottle of olive oil (visit one), a 
bag of nuts (almonds or walnuts) and a $10.00 Sprouts gift card (visit two). There are no foreseeable risks 
to your participation. 
Study results could be used in presentations, or publications, but your name will not be reported. Any 
reporting of results will be in aggregate form only. The pre and post assessments will be linked in a group 
form and not on an individual level.  
 
If you agree to participate in this study, please return this signed consent and the pre-questionnaire in the 
attached envelope to the front desk at check out, attention to: Ana Maria Burger. 
If you have any questions concerning the program, please contact the study team: Ana Maria Burger, 
DNP student at 520-304-3392 or at aburger2@asu.edu; or Dr. Lynda Root DNP, PMHCNS-BC at (602) 
496-0810 or Lynda.Root@asu.edu 
 
If you feel you have been placed at risk, you can contact the Chair of the Human Subjects Institutional 
Review Board, through the ASU Office of Research Integrity and Assurance, at (480) 965-6788.  
By signing below, you are agreeing to participate in this study.  
 
Name:   
 
Signature:       Date: 
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Appendix P 
Table 1 
Intervention Timeline 
Week 0 Recruitment: 
● Informational Flyers (Appendix M) were posted in the clinic waiting 
room.  
● Eligible patients were identified (patients with diabetes type 2, adults > 
18 years of age, male-female) by the physicians, nurse practitioners, 
medical assistants and/or receptionists. All established or new patients 
with a diagnosis of type 2 diabetes were given an informational flyer. 
● Interested participants were contacted by phone and in person (at site) 
by DNP student. 
 
Week 1 
 
Session 1 
First 
intervention 
 
● Written informed consent (Appendix O) was obtained from eligible 
participants by DNP student. 
● Weight was recorded by the medical assistant and documented in the 
patient's electronic medical record (EMR). 
● Per routine visit protocol, the Hemoglobin A1c was drawn by the 
laboratory phlebotomist at the clinic and recorded in the patient’s 
electronic medical record (EMR). 
 
Session one.  
DNP student: 
●  Provided an overview of the program explaining to the participants 
what the program entails including: number of sessions, diet guidelines 
and recommendations.  
● Administered the 14-Item Mediterranean Diet Assessment Tool 
(Appendix I) 
● Reviewed the dietary content for session 1. Using the Mediterranean 
Diet General Guidelines handout (oils, dressing, nuts, fish and meats) 
(Appendix N). 
● Reviewed Diet Goals Handout (Appendix L) (used for session one and 
three). 
● A tailored action plan was developed by the DNP student and the 
participant by highlighting potential areas for dietary improvement as 
identified by the Mediterranean Diet General Guidelines. 
● Assisted the patient to select from the Diet Goals Handout two 
achievable diet modification goals to work on before the next 
counseling session. 
 
At the conclusion of session 1, participants received a bottle of olive oil 
(medium size) and a Sprouts gift card with a value of $10.00 to buy fruits and 
vegetables. 
 
 
Week 2 No activities this week. 
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Week 3 
 
Session 2 
 
● Phone call (approx. 5-15 minutes) to review content from session 1 and 
to identify progress on reaching goals were made. (questions to ask: do 
you remember your goals? were you able to follow your goals? if not, 
how can I assist you to achieve your goals?) 
 
Week 4 
 
No activities this week. 
Week 5 
 
Session 3 
 
Session three.  
● Each participant received counseling on the dietary content of the 
following foods: Beverages, desserts, fruits and vegetables, grains and 
beans (based on the Mediterranean Diet General Guidelines) 
● Selected another two achievable goals. 
● Administered the 14-Item Mediterranean Diet Assessment Tool  
 
At the end of the session participants received a bag of nuts –medium size-
(walnuts or almonds according to participant preference). 
 
Week 6 
 
No activities this week. 
Week 7 
 
Session 4 
 
 
● Phone call (approx. 5-15 minutes) to review content from session 3 and 
to identify progress on reaching goals were made. (questions to ask: do 
you remember your goals? were you able to follow your goals? if not, 
how can I assist you to achieve your goals?) 
 
Week 8 Beginning of post assessment sessions. 
 
 
Post 
assessment  
During their routine follow up visit with their provider: 
● Weight was recorded by the medical assistant and documented in the 
patient's electronic medical record (EMR). 
● Per routine visit protocol, the Hemoglobin A1c was drawn by the 
laboratory phlebotomist at the clinic and recorded in the patient’s 
electronic medical record (EMR). 
● Outcomes of the project were reviewed with each participant at the 
clinic (hemoglobin A1c, weight and results of Mediterranean 
Assessment Tool)  
 
 
